drugset / Trial / NCT07169916
Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer
Not yet recruiting
210 enrolled
Fudan University
Minhang Central Hospital · collabShanghai Geriatric Medical Center · collabShanghai Zhongshan Hospital · collabXuhui Central Hospital, Shanghai · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the impact of Yueju Pill on quality of life and treatment efficacy in patients with advanced biliary tract cancer (BTC) receiving standard therapy.
Timeline
- Start
- 2025-09-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Yueju Pill | Unknown | 6 g | Oral |
| Subject | Yueju Pill | Unknown | 9 g | Oral |